Cargando…

Pharmaceutical Drugs of Uncertain Value, Lifecycle Regulation at the US Food and Drug Administration, and Institutional Incumbency

POLICY POINTS: The US Food and Drug Administration (FDA) has in recent years allowed onto the market several drugs with limited evidence of safety and effectiveness, provided that manufacturers agree to carry out additional studies while the drugs are in clinical use. Studies suggest that these post...

Descripción completa

Detalles Bibliográficos
Autor principal:	HERDER, MATTHEW
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Scholarship
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739605/ https://www.ncbi.nlm.nih.gov/pubmed/31407412 http://dx.doi.org/10.1111/1468-0009.12413

Ejemplares similares

Approval of Cancer Drugs With Uncertain Therapeutic Value: A Comparison of Regulatory Decisions in Europe and the United States
por: SALCHER‐KONRAD, MAXIMILIAN, et al.
Publicado: (2020)

A Value Sensitive Scenario Planning Method for Adaptation to Uncertain Future Sea Level Rise
por: Wedin, Anna, et al.
Publicado: (2021)

Less Is More: Norwegian Drug Regulation, Antibiotic Policy, and the “Need Clause”
por: HOBÆK, BÅRD, et al.
Publicado: (2019)

Coverage of New Drugs in Medicare Part D
por: NACI, HUSEYIN, et al.
Publicado: (2022)

Vaccines, pharmaceutical products, and bioterrorism: challenges for the U.S. Food and Drug Administration.
por: Zoon, K C
Publicado: (1999)

US State Policies, Politics, and Life Expectancy
por: MONTEZ, JENNIFER KARAS, et al.
Publicado: (2020)

Understanding Value Change in the Energy Transition: Exploring the Perspective of Original Institutional Economics
por: Correljé, Aad, et al.
Publicado: (2022)

Solid Pseudopapillary Neoplasm: A Single Institutional Case Series of a Rare Pancreatic Tumor
por: Oase, Kristen, et al.
Publicado: (2022)

Incumbents’ Capabilities for Sustainability-Oriented Innovation in the Norwegian Food Sector—an Integrated Framework
por: Gonera, Antje, et al.
Publicado: (2022)

The Duty Incumbent upon Dentists to Attend Associations
por: Ford, Arthur S.
Publicado: (1871)

Which factors influence the prevalence of institution‐acquired falls? Results from an international, multi‐center, cross‐sectional survey
por: Hoedl, Manuela, et al.
Publicado: (2021)

What Does the State Innovation Model Experiment Tell Us About States’ Capacity to Implement Complex Health Reforms?
por: BOXALL, ANNE‐MARIE
Publicado: (2022)

Characteristics of Distress and Support Group Participation in Caregivers of Older Allogeneic Hematopoietic Cell Transplantation Patients: A Single Institution Retrospective Review
por: Elko, Theresa A., et al.
Publicado: (2023)

FDA Sodium Reduction Targets and the Food Industry: Are There Incentives to Reformulate? Microsimulation Cost‐Effectiveness Analysis
por: COLLINS, BRENDAN, et al.
Publicado: (2019)

Disagreements Within the US Food and Drug Administration Regarding Approval of Novel Therapeutic Agents, 2011-2015
por: MacGregor, Andrea, et al.
Publicado: (2020)

Unapproved Pharmaceutical Ingredients Included in Dietary Supplements Associated With US Food and Drug Administration Warnings
por: Tucker, Jenna, et al.
Publicado: (2018)

Audit of Data Sharing by Pharmaceutical Companies for Anticancer Medicines Approved by the US Food and Drug Administration
por: Modi, Natansh D., et al.
Publicado: (2022)

Cancer drugs: high price, uncertain value
por: Cohen, Deborah
Publicado: (2017)

The local economy and Re-election of incumbent district leaders in Indonesia
por: Rumayya, et al.
Publicado: (2020)

Identities of the incumbent and the successor in the family business succession: Review and prospects
por: Li, Weining, et al.
Publicado: (2023)

Exploring the Food and Drug Administration’s review and approval of Entresto (sacubitril/valsartan)
por: Eadie, Ashley L., et al.
Publicado: (2021)

Lifecycle management of orphan drugs approved in Japan
por: Seki, Kiyoshi, et al.
Publicado: (2022)

Co-creating Research Integrity Education Guidelines for Research Institutions
por: Labib, Krishma, et al.
Publicado: (2023)

Cyberpharmacies and the role of the US Food And Drug Administration
por: Henney, Jane E
Publicado: (2001)

The US Food and Drug Administration’s Intersection with Dermatology
por: Luke, Markham C.
Publicado: (2022)

Benefits of Teaching Medical Students How to Communicate with Patients Having Serious Illness: Comparison of Two Approaches to Experiential, Skill-Based, and Self-Reflective Learning
por: Ellman, Matthew S., et al.
Publicado: (2012)

Strategic Wholesale Pricing for an Incumbent Supplier Facing with a Competitive Counterpart
por: Sun, Jianwu
Publicado: (2014)

Closest to the People? Incumbency Advantage and the Personal Vote in Non-Partisan Elections
por: Lucas, Jack, et al.
Publicado: (2021)

Life Satisfaction and Incumbent Voting: Examining the Mediating Effect of Trust in Government
por: Ng, Jason Wei Jian, et al.
Publicado: (2022)

A Pharmacist-Led Oral Chemotherapy Program's Impact on Chronic Myeloid Leukemia Patient Satisfaction, Adherence, and Outcomes
por: Dennison, Taylor, et al.
Publicado: (2021)

Understanding Barriers to Oral Therapy Adherence in Adults With Acute Myeloid Leukemia
por: Bryant, Ashley Leak, et al.
Publicado: (2020)

What do Retraction Notices Reveal About Institutional Investigations into Allegations Underlying Retractions?
por: Xu, Shaoxiong Brian, et al.
Publicado: (2023)

Characteristics of Recent Generic Drug Approvals by the US Food and Drug Administration
por: Jiao, Kuo, et al.
Publicado: (2019)

Use of Extrapolation in New Drug Approvals by the US Food and Drug Administration
por: Feldman, Daniel, et al.
Publicado: (2022)

The U.S. Food and Drug Administration: Drug Information Resource for Formulary Recommendations
por: Marchand, Heidi C., et al.
Publicado: (2012)

Authorship Policies at U.S. Doctoral Universities: A Review and Recommendations for Future Policies
por: Rasmussen, Lisa M., et al.
Publicado: (2020)

Achieving a ‘Good AI Society’: Comparing the Aims and Progress of the EU and the US
por: Roberts, Huw, et al.
Publicado: (2021)

Parity and the Resolution of Value Conflicts in Design
por: Kozlovski, Atay
Publicado: (2022)

How to Weigh Values in Value Sensitive Design: A Best Worst Method Approach for the Case of Smart Metering
por: van de Kaa, Geerten, et al.
Publicado: (2019)

Epistemic and Non-epistemic Values in Earthquake Engineering
por: Zanetti, Luca, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a052s4tdmf7jsk1ogtcepsopvg